As of 2026-04-19, the Relative Valuation of Oramed Pharmaceuticals Inc (ORMP) is 19.34 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.88 USD, the upside of Oramed Pharmaceuticals Inc based on Relative Valuation is 398.4%.
The range of the Relative Valuation is 16.57 - 21.66 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 19.7x | 18.4x |
| Forward P/E multiples | 15.0x - 18.5x | 16.8x |
| Fair Price | 16.57 - 21.66 | 19.34 |
| Upside | 327.1% - 458.3% | 398.4% |
| Date | P/E |
| 2026-04-16 | 3.50 |
| 2026-04-15 | 3.47 |
| 2026-04-14 | 3.45 |
| 2026-04-13 | 3.44 |
| 2026-04-10 | 3.20 |
| 2026-04-09 | 3.19 |
| 2026-04-08 | 3.16 |
| 2026-04-07 | 3.19 |
| 2026-04-06 | 3.12 |
| 2026-04-02 | 3.10 |
| 2026-04-01 | 3.08 |
| 2026-03-31 | 3.09 |
| 2026-03-30 | 2.98 |
| 2026-03-27 | 3.00 |
| 2026-03-26 | 3.01 |
| 2026-03-25 | 3.18 |
| 2026-03-24 | 3.10 |
| 2026-03-23 | 3.22 |
| 2026-03-20 | 3.17 |
| 2026-03-19 | 3.28 |
| 2026-03-18 | 3.24 |
| 2026-03-17 | 3.28 |
| 2026-03-16 | 3.18 |
| 2026-03-13 | 3.11 |
| 2026-03-12 | 3.07 |
| 2026-03-11 | 3.09 |
| 2026-03-10 | 3.02 |
| 2026-03-09 | 2.96 |
| 2026-03-06 | 2.98 |
| 2026-03-05 | 3.09 |
| 2026-03-04 | 3.29 |
| 2026-03-03 | 3.07 |
| 2026-03-02 | 3.03 |
| 2026-02-27 | 3.10 |
| 2026-02-26 | 3.11 |
| 2026-02-25 | 3.39 |
| 2026-02-24 | 3.14 |
| 2026-02-23 | 3.00 |
| 2026-02-20 | 2.92 |
| 2026-02-19 | 2.88 |
| 2026-02-18 | 3.00 |
| 2026-02-17 | 2.90 |
| 2026-02-13 | 2.95 |
| 2026-02-12 | 2.88 |
| 2026-02-11 | 2.95 |
| 2026-02-10 | 3.07 |
| 2026-02-09 | 3.11 |
| 2026-02-06 | 3.09 |
| 2026-02-05 | 2.94 |
| 2026-02-04 | 3.10 |